Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Registry following how acute stroke patients are treated and how they fare

Records stroke treatments in adults and compares them with later recovery and survival.

Plain-language title generated from the registry record
Registry title: Giessen Stroke Registry

Key facts

Where
Giessen, GermanySee the site

Where in Germany

  • Universitätsklinikum GießenGiessen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Giessen
Trial code
NCT05295862
Record updated
1 December 2023
Original description
The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.Read full original descriptionShow less

Giessen Acute Stroke Registry

The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.

Inclusion: Age above 18; Patient admitted for acute stroke (Stroke Unit or Intensive Care Unit); Informed Consent.

Exclusion: Inclusion criteria not met.

ClinicalTrials.gov NCT05295862